These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

720 related articles for article (PubMed ID: 18785066)

  • 1. Suppression of Na+/H+ exchanger isoform-3 in human inflammatory bowel disease: lack of reversal by 5'-aminosalicylate treatment.
    Siddique I; Hasan F; Khan I
    Scand J Gastroenterol; 2009; 44(1):56-64. PubMed ID: 18785066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Na+/H+ exchanger isoform-1 in human inflammatory bowel disease.
    Khan I; Siddique I; Al-Awadi FM; Mohan K
    Can J Gastroenterol; 2003 Jan; 17(1):31-6. PubMed ID: 12560852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-8 and SDF1-alpha mRNA expression in colonic biopsies from patients with inflammatory bowel disease.
    Katsuta T; Lim C; Shimoda K; Shibuta K; Mitra P; Banner BF; Mori M; Barnard GF
    Am J Gastroenterol; 2000 Nov; 95(11):3157-64. PubMed ID: 11095335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis.
    Olsen T; Goll R; Cui G; Husebekk A; Vonen B; Birketvedt GS; Florholmen J
    Scand J Gastroenterol; 2007 Nov; 42(11):1312-20. PubMed ID: 17852866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of tumor necrosis factor-alpha messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase.
    Akazawa A; Sakaida I; Higaki S; Kubo Y; Uchida K; Okita K
    J Gastroenterol; 2002; 37(5):345-53. PubMed ID: 12051533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colitis-induced changes in the expression of the Na+/H+ exchanger isoform NHE-1.
    Khan I; al-Awadi FM; Abul H
    J Pharmacol Exp Ther; 1998 May; 285(2):869-75. PubMed ID: 9580638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
    Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
    Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multigene analysis can discriminate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome.
    von Stein P; Lofberg R; Kuznetsov NV; Gielen AW; Persson JO; Sundberg R; Hellstrom K; Eriksson A; Befrits R; Ost A; von Stein OD
    Gastroenterology; 2008 Jun; 134(7):1869-81; quiz 2153-4. PubMed ID: 18466904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of real-time polymerase chain reaction for quantifying TNF-alpha mRNA expression in inflamed colorectal mucosa: an approach to optimize procedures for clinical use.
    Cui G; Olsen T; Christiansen I; Vonen B; Florholmen J; Goll R
    Scand J Clin Lab Invest; 2006; 66(3):249-59. PubMed ID: 16714253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.
    Banks C; Bateman A; Payne R; Johnson P; Sheron N
    J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of intestinal cytokine messenger RNA profile by real-time quantitative polymerase chain reaction in patients with inflammatory bowel disease.
    Sawa Y; Oshitani N; Adachi K; Higuchi K; Matsumoto T; Arakawa T
    Int J Mol Med; 2003 Feb; 11(2):175-9. PubMed ID: 12525873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on the influence of Candida fungal colonization on the healing process of inflammatory lesions in the colon in rat animal model].
    Zwolińska-Wcisło M; Brzozowski T; Budak A; Sliwowski Z; Drozdowicz D; Kwiecień S; Trojanowska D; Rudnicka-Sosin L; Mach T; Konturek SJ; Pawlik WW; Targosz A
    Przegl Lek; 2007; 64(3):124-9. PubMed ID: 17941462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal cytokine production in radiation-induced proctosigmoiditis compared with inflammatory bowel disease.
    Indaram AV; Visvalingam V; Locke M; Bank S
    Am J Gastroenterol; 2000 May; 95(5):1221-5. PubMed ID: 10811331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance P receptor expression in patients with inflammatory bowel disease. Determination by three different techniques, i.e., storage phosphor autoradiography, RT-PCR and immunohistochemistry.
    ter Beek WP; Biemond I; Muller ES; van den Berg M; Lamers CB
    Neuropeptides; 2007 Oct; 41(5):301-6. PubMed ID: 17602742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From model cell line to in vivo gene expression: disease-related intestinal gene expression in IBD.
    Schulze HA; Häsler R; Mah N; Lu T; Nikolaus S; Costello CM; Schreiber S
    Genes Immun; 2008 Apr; 9(3):240-8. PubMed ID: 18340362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha.
    Otani T; Yamaguchi K; Scherl E; Du B; Tai HH; Greifer M; Petrovic L; Daikoku T; Dey SK; Subbaramaiah K; Dannenberg AJ
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G361-8. PubMed ID: 16195422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of angiogenic factors in the VEGF-Ets-1 cascades in inflammatory bowel disease.
    Konno S; Iizuka M; Yukawa M; Sasaki K; Sato A; Horie Y; Nanjo H; Fukushima T; Watanabe S
    J Gastroenterol; 2004 Oct; 39(10):931-9. PubMed ID: 15549445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease.
    Wolf AM; Wolf D; Rumpold H; Moschen AR; Kaser A; Obrist P; Fuchs D; Brandacher G; Winkler C; Geboes K; Rutgeerts P; Tilg H
    Clin Immunol; 2004 Oct; 113(1):47-55. PubMed ID: 15380529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.